These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 33239079)

  • 1. Feasibility and initial efficacy of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability: study protocol for a single-group, feasibility trial.
    Hubbard EA; Motl RW; Elmer DJ
    Trials; 2020 Nov; 21(1):972. PubMed ID: 33239079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a feasibility and initial efficacy clinical trial of a high-intensity interval training program using adaptive equipment in persons with multiple sclerosis who have walking disability.
    Silveira SL; Motl RW; Elmer DJ; Botkin T; Ontiveros T; Williams S; Hubbard EA
    Mult Scler Relat Disord; 2024 Jul; 87():105695. PubMed ID: 38820697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity interval training and energy management education, compared with moderate continuous training and progressive muscle relaxation, for improving health-related quality of life in persons with multiple sclerosis: study protocol of a randomized controlled superiority trial with six months' follow-up.
    Patt N; Kool J; Hersche R; Oberste M; Walzik D; Joisten N; Caminada D; Ferrara F; Gonzenbach R; Nigg CR; Kamm CP; Zimmer P; Bansi J
    BMC Neurol; 2021 Feb; 21(1):65. PubMed ID: 33573608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cycling in primary progressive multiple sclerosis (CYPRO): study protocol for a randomized controlled superiority trial evaluating the effects of high-intensity interval training in persons with primary progressive multiple sclerosis.
    Kupjetz M; Joisten N; Rademacher A; Gonzenbach R; Bansi J; Zimmer P
    BMC Neurol; 2023 Apr; 23(1):162. PubMed ID: 37087424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.
    Joisten N; Rademacher A; Bloch W; Schenk A; Oberste M; Dalgas U; Langdon D; Caminada D; Purde MT; Gonzenbach R; Kool J; Zimmer P; Bansi J
    BMC Neurol; 2019 Mar; 19(1):37. PubMed ID: 30849952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute High-Intensity Interval Exercise in Multiple Sclerosis with Mobility Disability.
    Hubbard EA; Motl RW; Fernhall BO
    Med Sci Sports Exerc; 2019 May; 51(5):858-867. PubMed ID: 30531291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-duration aerobic high-intensity intervals versus moderate exercise training intensity in patients with peripheral artery disease: study protocol for a randomised controlled trial (the Angiof-HIIT Study).
    Lanzi S; Pousaz A; Fresa M; Besson C; Desgraz B; Gremeaux-Bader V; Mazzolai L
    BMJ Open; 2024 Apr; 14(4):e081883. PubMed ID: 38631833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aerobic capacity - fatigue relationship in persons with Multiple Sclerosis is not reproducible in a pooled analysis of two randomized controlled trials.
    Wolf F; Rademacher A; Joisten N; Proschinger S; Schlagheck ML; Bloch W; Gonzenbach R; Kool J; Bansi J; Zimmer P
    Mult Scler Relat Disord; 2022 Feb; 58():103476. PubMed ID: 35065407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is High-Intensity Interval Training More Effective Than Moderate Continuous Training in Rehabilitation of Multiple Sclerosis: A Comprehensive Systematic Review and Meta-analysis.
    Youssef H; Gönül MN; Sobeeh MG; Akar K; Feys P; Cuypers K; Vural A
    Arch Phys Med Rehabil; 2024 Aug; 105(8):1545-1558. PubMed ID: 38199581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.
    Straudi S; Manfredini F; Lamberti N; Zamboni P; Bernardi F; Marchetti G; Pinton P; Bonora M; Secchiero P; Tisato V; Volpato S; Basaglia N
    Trials; 2017 Feb; 18(1):88. PubMed ID: 28241776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remotely-delivered exercise training program for improving physical and cognitive functions among older adults with multiple sclerosis: Protocol for an NIH stage-I randomized controlled trial.
    Zheng P; Phillips SA; Duffecy J; DeJonge SR; DuBose NG; Motl RW
    Contemp Clin Trials; 2024 Sep; 144():107636. PubMed ID: 39038700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate-intensity exercise versus high-intensity interval training to recover walking post-stroke: protocol for a randomized controlled trial.
    Miller A; Reisman DS; Billinger SA; Dunning K; Doren S; Ward J; Wright H; Wagner E; Carl D; Gerson M; Awosika O; Khoury J; Kissela B; Boyne P
    Trials; 2021 Jul; 22(1):457. PubMed ID: 34271979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High INtensity Interval Training In pATiEnts with intermittent claudication (INITIATE): protocol for a multicentre, proof-of-concept, prospective interventional study.
    Pymer S; Harwood A; Ibeggazene S; McGregor G; Huang C; Twiddy M; Nicholls AR; Ingle L; Carroll S; Long J; Rooms M; Chetter IC;
    BMJ Open; 2020 Jul; 10(7):e038825. PubMed ID: 32636290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inpatient energy management education and high-intensity interval training on health-related quality of life in persons with multiple sclerosis: A randomized controlled superiority trial with six-month follow-up.
    Patt N; Kupjetz M; Kool J; Hersche R; Oberste M; Joisten N; Gonzenbach R; Nigg CR; Zimmer P; Bansi J
    Mult Scler Relat Disord; 2023 Oct; 78():104929. PubMed ID: 37579643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn's disease: study protocol for a randomised controlled trial.
    Tew GA; Carpenter R; Seed M; Anderson S; Langmead L; Fairhurst C; Bottoms L
    Pilot Feasibility Stud; 2017; 3():17. PubMed ID: 28373911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple Sclerosis.
    Motl RW; Backus D; Neal WN; Cutter G; Palmer L; McBurney R; Schmidt H; Bethoux F; Hebert J; Ng A; McCully KK; Plummer P
    Contemp Clin Trials; 2019 Jun; 81():110-122. PubMed ID: 31022481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental protocol of a randomized controlled clinical trial investigating exercise, subclinical atherosclerosis, and walking mobility in persons with multiple sclerosis.
    Griffith G; Klaren RE; Motl RW; Baynard T; Fernhall B
    Contemp Clin Trials; 2015 Mar; 41():280-6. PubMed ID: 25687666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of high-intensity, low-volume interval training compared to continuous aerobic training on insulin resistance, skeletal muscle structure and function in adults with metabolic syndrome: study protocol for a randomized controlled clinical trial (Intraining-MET).
    Gallo-Villegas J; Aristizabal JC; Estrada M; Valbuena LH; Narvaez-Sanchez R; Osorio J; Aguirre-Acevedo DC; Calderón JC
    Trials; 2018 Feb; 19(1):144. PubMed ID: 29482601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
    Coote S; Gallagher S; Msetfi R; Larkin A; Newell J; Motl RW; Hayes S
    BMC Neurol; 2014 Dec; 14():241. PubMed ID: 25528262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do baseline cognitive status, participant specific characteristics and EDSS impact changes of cognitive performance following aerobic exercise intervention in multiple sclerosis?
    Rademacher A; Joisten N; Proschinger S; Hebchen J; Schlagheck ML; Bloch W; Gonzenbach R; Kool J; Bansi J; Zimmer P
    Mult Scler Relat Disord; 2021 Jun; 51():102905. PubMed ID: 33836459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.